Registry Following Adults With Diabetes, Blood Pressure, Heart or Kidney Disease
Records how adults with type 2 diabetes, hypertension, heart failure or kidney disease are managed.
Plain-language title generated from the registry record
Registry title: iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Key facts
- Where
- Bulacan, Cebu City, Iloilo City, Laguna, Mandaluyong, Manila, Mindoro, Pampanga, Quezon City, and Zamboanga City, PhilippinesSee the 10 sites
Where in Philippines
- BulacanBulacan, PhilippinesNot yet recruiting
- Cebu CityCebu City, PhilippinesTaking people
- Iloilo CityIloilo City, PhilippinesNot yet recruiting
- LagunaLaguna, PhilippinesNot yet recruiting
- MandaluyongMandaluyong, PhilippinesNot yet recruiting
- ManilaManila, PhilippinesNot yet recruiting
- MindoroMindoro, PhilippinesNot yet recruiting
- PampangaPampanga, PhilippinesNot yet recruiting
- Quezon CityQuezon City, PhilippinesNot yet recruiting
- Zamboanga CityZamboanga City, PhilippinesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AstraZeneca
- Trial code
- NCT03549754
- Record updated
- 9 September 2026
- Original description
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseasesRead full original descriptionShow less
Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Inclusion: Being 18 years or older; Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease; Providing written informed consent to participate in the registry.
Exclusion: Having a life-threatening co-morbidity with life expectancy below 1 year; Participating in an interventional trial requiring informed consent.